- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Metastatic Hormone-Sensitive Prostate Cancer in New Zealand
Total 3108 results
-
Molecular Insight Pharmaceuticals, Inc.Completed
-
RhoVac APSActive, not recruitingProstate Cancer RecurrentSweden, United States, Finland, United Kingdom, Belgium, Germany, Denmark
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.Active, not recruitingProstate Cancer | Cancer of the Prostate | Nonmetastatic Castration-Resistant Prostate CancerHong Kong, Canada, China, Germany, Spain, Netherlands, United Kingdom, Korea, Republic of, Taiwan, Australia, Denmark, France, United States, Singapore, Poland, Malaysia, Turkey, Belgium, Argentina, Thailand, Slovakia, Brazil, Finland, Ita... and more
-
Royal North Shore HospitalCompletedCancer of the ProstateAustralia
-
Janssen Inc.Completed
-
Innocrin PharmaceuticalProstate Cancer Foundation; Prostate Cancer Clinical Trials ConsortiumCompleted
-
Memorial Sloan Kettering Cancer CenterRecruitingBreast Cancer | Colorectal Cancer | Prostate Cancer | Stage I Breast Cancer | Stage II Breast Cancer | Stage I Prostate Cancer | Stage II Prostate Cancer | Stage III Prostate Cancer | Stage III Breast Cancer | Stage III Colorectal Cancer | Stage I Colorectal Cancer | Stage II Colorectal CancerUnited States
-
Millennium Pharmaceuticals, Inc.CompletedProstate CancerUnited States
-
National Cancer Institute (NCI)Wayne State University; Columbia University; University of Pittsburgh; University... and other collaboratorsCompleted
-
Rutgers, The State University of New JerseyBristol-Myers Squibb; National Cancer Institute (NCI)CompletedProstate CancerUnited States
-
Nymox CorporationCompletedProstate CancerUnited States
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)Completed
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedProstate CancerUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)Completed
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedProstate CancerUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedProstate CancerUnited States
-
Weill Medical College of Cornell UniversityCompletedProstate CancerUnited States
-
Memorial Sloan Kettering Cancer CenterAureon Biosciences, Inc.; NYU MEDICAL CENTERCompleted
-
Herbert Irving Comprehensive Cancer CenterUnknownProstate CancerUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)Completed
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedProstate CancerUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)Completed
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)Completed
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedProstate CancerUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedProstate CancerUnited States
-
M.D. Anderson Cancer CenterUnknownProstate CancerUnited States
-
Dana-Farber Cancer InstituteBristol-Myers Squibb; Massachusetts General Hospital; Beth Israel Deaconess Medical... and other collaboratorsCompletedProstate CancerUnited States
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI)CompletedMetastatic CancerCanada, United States
-
Memorial Sloan Kettering Cancer CenterCompleted
-
Herbert Irving Comprehensive Cancer CenterUnknownProstate CancerUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)Completed
-
Memorial Sloan Kettering Cancer CenterCompleted
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)Completed
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)Completed
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedProstate CancerUnited States
-
NYU Langone HealthNational Cancer Institute (NCI)CompletedProstate CancerUnited States
-
Hoffmann-La RocheCompletedLocally Advanced Solid Tumors | Metastatic Solid TumorsUnited States, Korea, Republic of
-
AmgenActive, not recruitingNeuroendocrine Prostate CancerBelgium, United States, Austria, Spain, Australia, Netherlands, France, United Kingdom, Japan
-
National Cancer Institute (NCI)WithdrawnAnatomic Stage IV Breast Cancer AJCC v8 | Castration-Resistant Prostate Carcinoma | Stage IVB Prostate Cancer AJCC v8United States
-
Incyte Biosciences International SàrlCompletedMetastatic Cancer | Advanced MalignanciesUnited States, United Kingdom, Spain, Switzerland
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI); National Institutes of Health (NIH); Virginia...CompletedBreast Cancer | Lung Cancer | Prostate CancerUnited States
-
Rutgers, The State University of New JerseyRecruitingMetastatic Cancer | Radiation TherapyUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedHead and Neck Cancer | Prostate CancerUnited States
-
National Cancer Institute (NCI)CompletedProstate Adenocarcinoma | Recurrent Prostate Carcinoma | Stage IV Prostate CancerUnited States, Canada
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); National Institutes of Health (NIH)CompletedStage I Breast Cancer | Stage II Breast Cancer | Stage I Prostate Cancer | Stage II Prostate Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage III Colorectal Cancer AJCC v7 | Stage IIIA Colorectal Cancer AJCC v7 | Stage IIIB Colorectal Cancer... and other conditionsUnited States
-
Eli Lilly and CompanyCompletedProstate CancerUnited States
-
Zealand University HospitalCompletedMetastatic Nonsmall Cell Lung CancerDenmark
-
Advaxis, Inc.TerminatedMetastatic Melanoma | Urothelial Carcinoma | Metastatic Non-Small Cell Lung Cancer | Head and Neck Cancer Metastatic | Colon Cancer MetastaticUnited States
-
Mirati Therapeutics Inc.RecruitingMetastatic Cancer | Advanced Cancer | Malignant Neoplastic DiseaseUnited States, Puerto Rico
-
Prostate Cancer Clinical Trials ConsortiumUniversity of Chicago; Astellas Pharma IncTerminatedProstate CancerUnited States